ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is 60 Degrees Pharmaceuticals, Inc. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -85.65% and Operating profit at -143.04% over the last 5 years
2
Flat results in Mar 26
- OPERATING CASH FLOW(Y) Lowest at USD -7.99 MM
- INTEREST(HY) At USD 0 MM has Grown at 39.32%
- RAW MATERIAL COST(Y) Grown by 34.5% (YoY)
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -80.47%, its profits have risen by 17.5%
4
Below par performance in long term as well as near term
- Along with generating -80.47% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is 60 Degrees Pharmaceuticals, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
60 Degrees Pharmaceuticals, Inc.
-80.47%
-0.30
305.41%
S&P 500
22.24%
1.67
13.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-85.65%
EBIT Growth (5y)
-143.04%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.80
Sales to Capital Employed (avg)
0.15
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.37%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.84
EV to EBIT
0.03
EV to EBITDA
0.03
EV to Capital Employed
-0.25
EV to Sales
-0.19
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-176.06%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
NET PROFIT(HY)
Higher at USD -3.94 MM
NET SALES(9M)
Higher at USD 1.01 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 3.19 times
EPS(Q)
Highest at USD -1.28
-8What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -7.99 MM
INTEREST(HY)
At USD 0 MM has Grown at 39.32%
RAW MATERIAL COST(Y)
Grown by 34.5% (YoY
Here's what is working for 60 Degrees Pharmaceuticals, Inc.
Net Profit
Higher at USD -3.94 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Sales
At USD 1.01 MM has Grown at 48.83%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
EPS
Highest at USD -1.28
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debtors Turnover Ratio
Highest at 3.19 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Sales
Higher at USD 1.01 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Here's what is not working for 60 Degrees Pharmaceuticals, Inc.
Operating Cash Flow
Lowest at USD -7.99 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Interest
At USD 0 MM has Grown at 39.32%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Raw Material Cost
Grown by 34.5% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
